[Expression of c-erbB-2 and c-met proteins in gastric adenoma and adenocarcinoma]

Korean J Gastroenterol. 2007 Mar;49(3):152-7.
[Article in Korean]

Abstract

Background/aims: The aim of this study was to investigate the immunohistochemical overexpression of c-erbB-2 and c-met proteins according to the histopathological parameters such as grade of dysplasia, histological type, depth of invasion, lymph node metastasis, and TNM stage in gastric adenoma and gastric adenocarcinoma.

Methods: Immunohistochemical staining using monoclonal c-erbB-2 and c-met antibodies was performed on paraffin embedded specimens in 43 adenomas and 44 adenocarcinomas.

Results: The expression rate of c-erbB-2 was higher in adenomas (91%) than adenocarcinomas (30%). The expression rate of c-met was higher in adenocarcinomas (77%) than adenomas (49%). In adenoma, the expression rate of c-met was higher in high grade dysplasia (94%) than in low grade dysplasia (22%). In adenocarcinoma, c-met expression was significantly related with lymph node metastasis.

Conclusions: c-erbB-2 would be involved in the development of relatively early stage gastric carcinogenesis. c-erbB-2 is related with histologic type and c-met with lymph node metastasis in gastric carcinomas. Although meaning for the expression of these proteins in gastric carcinomas would be different, these proteins may play as important oncogenes in gastric carcinogenesis.

Publication types

  • English Abstract

MeSH terms

  • Adenocarcinoma / metabolism*
  • Adenocarcinoma / pathology
  • Adenoma / metabolism*
  • Adenoma / pathology
  • Aged
  • Antibodies, Monoclonal
  • Biomarkers, Tumor
  • Disease Progression
  • Female
  • Humans
  • Immunohistochemistry
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Proto-Oncogene Proteins c-met / immunology
  • Proto-Oncogene Proteins c-met / metabolism*
  • Receptor, ErbB-2 / immunology
  • Receptor, ErbB-2 / metabolism*
  • Stomach Neoplasms / metabolism*
  • Stomach Neoplasms / pathology

Substances

  • Antibodies, Monoclonal
  • Biomarkers, Tumor
  • Proto-Oncogene Proteins c-met
  • Receptor, ErbB-2